Volume 5, Emitir 3 (2008)
Artigo de Revisão
Therapeutic human papillomavirus vaccination
Andreas M Kaufmann and Achim Schneider
Artigo de Revisão
Efficacy of a prophylactic human papillomavirus vaccine against high-grade vulval and vaginal intraepithelial neoplasia
Jorma Paavonen
Artigo de Revisão
Prophylactic human papillomavirus vaccines to prevent cervical cancer: review of the Phase II and III trials
Diane M Harper
Perspectiva
Evaluating the potential benefits of universal worldwide human papillomavirus vaccination
F Xavier Bosch, Silvia de Sanjosé and Xavier Castellsagué
Perspectiva
Human papillomavirus screening and vaccines for cancer prevention: what is on the horizon?
Cornelia L Trimble, Patti Gravitt and Richard BS Roden
Artigo de Revisão
What is the clinical utility of interferon-α release assays for the diagnosis of TB in high-TB-burden countries?
Peter Daley and Poorvi Chordia
Avaliação de Medicamentos
Tadalafil in the treatment of lower urinary tract symptoms and erectile dysfunction
Andrew Myatt and Ian Eardley
Relatório especial
Sound implementation of human papillomavirus vaccination as a community-randomized trial
M Lehtinen, KM French , J Dillner, J Paavonen & G Garnett
Destaques da Pesquisa
Highlights from the latest articles in human papillomavirus vaccination and cervical cancer research
Rachel Skinner & Julia Brotherton
Editorial
The need for actions to effectively prevent cervical cancer: priorities and future directions of EUROGIN
Joseph Monsonego
Editorial
Cross-protection from human papillomavirus 16/18 against types 45 and 31: fact or fancy?
Karen J Nishida , J Matthew Pearson and Leo B Twiggs
Prefácio
Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention
Eduardo L Franco and Jorma Paavonen
